Sort
11,323 grants matching “glioblastoma”
Differential Mapping of Stem Cells in Tumors
$289,741David M. Lubman · University Of Michigan At Ann Arbor · R01 · FY2015 · GM
Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain Tumors
$289,574Juan Fueyo · University Of Tx Md Anderson Can Ctr · P50 · FY2016 · CA
Differential Mapping of Stem Cells in Tumors
$289,547David M. Lubman · University Of Michigan At Ann Arbor · R01 · FY2016 · GM
Project 4: Inhibiting Novel Autophagy Mediator ATG4B for Treating Glioblastoma
$289,507Shi-Yuan Cheng · Northwestern University At Chicago · P50 · FY2022 · CA
phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma
$289,507Atique U. Ahmed · Northwestern University At Chicago · P50 · FY2022 · CA
Xenograft Model for Studying Amplified EGFR in GBM
$289,327Mayo Clinic · R01 · FY2005 · NS
Regulation of TGF-beta Signaling and Embryonic Development by GTPases
$289,308Gerald H Thomsen · State University New York Stony Brook · R01 · FY2008 · GM
Regulation of TGF-beta Signaling and Embryonic Development by GTPases
$289,308Gerald H Thomsen · State University New York Stony Brook · R01 · FY2009 · GM
Interrogation and interpretation of protein kinase signaling dynamics at single-cell resolution
$289,202Min Xue · University Of California Riverside · R35 · FY2020 · GM
Project 2: Analysis of non-cell autonomous heterotypic and homotypic cell-cell interaction in invasive cancer models
$289,198Gunter P. Wagner · Yale University · U54 · FY2016 · CA
Targeting MELK-mediated EZH2 signaling in glioma stem cells
$289,126Ichiro Nakano · University Of Alabama At Birmingham · R01 · FY2016 · NS
Development of Novel Inducers of Non-Apoptotic Cell Death to Target Glioblastoma
$288,999William A Maltese · University Of Toledo Health Sci Campus · R01 · FY2012 · CA
Molecular Oncogenic Properties of Mutant p53
$288,800Xinbin Chen · University Of California At Davis · R01 · FY2010 · CA
Molecular Imaging of Phospho-FADD and its role in resistance to therapy
$288,800Alnawaz Rehemtulla · University Of Michigan At Ann Arbor · R01 · FY2007 · CA
Molecular Oncogenic Properties of Mutant p53
$288,800Xinbin Chen · University Of California At Davis · R01 · FY2009 · CA
Molecular Oncogenic Properties of Mutant p53
$288,800Xinbin Chen · University Of California At Davis · R01 · FY2008 · CA
Improving Delivery of Molecularly-Targeted Therapy to Invasive Glioma Cells
$288,640William F Elmquist · University Of Minnesota · R01 · FY2013 · CA
Imaging and Tissue Biomarkers for Improved Management of Patients with Newly Diag
$288,637Sarah J. Nelson · University Of California, San Francisco · P01 · FY2011 · CA
Genomic & Genetic Characterization of Amplicons in GBMs
$288,607Lynda Chin · Dana-Farber Cancer Inst · R01 · FY2007 · CA
Molecular Imaging of Phospho-FADD and its role in resistance to therapy
$288,584Alnawaz Rehemtulla · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
Molecular Imaging of Phospho-FADD and its role in resistance to therapy
$288,584Alnawaz Rehemtulla · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
Molecular Imaging of Phospho-FADD and its role in resistance to therapy
$288,584Alnawaz Rehemtulla · University Of Michigan At Ann Arbor · R01 · FY2008 · CA
Targeting the OLIG2 Transcription Factor
$288,558Charles Stiles · Massachusetts General Hospital · P50 · FY2013 · CA
Molecular Oncogenic Properties of Mutant p53
$288,481Xinbin Chen · University Of California At Davis · R01 · FY2007 · CA
Project 1: Treatment of GBM using an oncolytic HSV engineered to improve immunogenic tumor destruction
$288,477Joseph C. Glorioso · Brigham And Women'S Hospital · P01 · FY2024 · CA